Private Equity Portfolio News: Hua Medicine Raises $117.4 Million in Series D & Series E Financing
Hua Medicine, a clinical-stage drug development company developing novel therapies for the treatment of Type 2 diabetes, announced the closing of a combined Series D & Series E financing of…